"The drug companies own the results of clinical trials," says Dr. Benjamin Kuo of Veterans General Hospital in Taipei. He explains that the companies frequently spend more than NT $ 100 million on a drug trial and it is they who decide whether to publish the results. They are naturally selective, releasing the positive conclusions and keeping quiet about the negative ones.
「臨床試驗的結果屬於出資的藥廠，」台北榮總教學部醫師郭英調指出，一項臨床試驗動輒耗資千萬元以上，藥廠對於結果是否發表有主控權，當然會選擇性地發表對其有利的結果，不利的結果則隱而不宣，民眾因此無法得知全貌。